ETH Zurich

Treating anaemia with gene scissors

ETH Zurich molecular biologist Mandy Boontanrart is researching gene therapies that could be used to cure two of the most common types of inherited anaemia. She has now developed a promising approach for so-called beta-hemoglobinopathies.

Voluntary carbon offsets often fail to deliver what they promise

Malte Toetzke calls for more ambitious standards in the voluntary carbon offset market. While this would lead to fewer projects getting funded, the benefit for the climate would be greater overall.

Using drones to monitor rainforest biodiversity

A team led by researchers from ETH Zurich and the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) advances to the finals of the XPRIZE Rainforest Competition. The international competition aims to promote the development of autonomous technologies for collecting data on biodiversity.

“Research with embryo models needs legal clarity”

Science often runs ahead of legislation – and this is now also true for research on embryo-like cell aggregates from human stem cells. Bioethicist Alessandro Blasimme of ETH Zurich explains why this controversial topic calls for legal clarity.

Treating bladder infections with viruses

The pathogens that cause urinary tract infections are becoming increasingly resistant to antibiotics. ETH Zurich researchers have now developed a rapid test and a new therapeutic approach using bacteria-infecting viruses known as phages.

How AI models teach themselves to learn new things

Large language models such as GPT-3 are able to learn new concepts by interacting with their users. Researchers at ETH and Google may now have uncovered a key mechanism behind this capability.

35 36 37

38

39 40 41 42...

Page 38 of 117